Pure Global

HCY Rapid Quantitative Test - India CDSCO Medical Device Registration

HCY Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000035_8cfbbd99a8097a32f8c4e33198fedaaf_eddebe058b0936f47f9007e5865e997f. The license holder is DIYA SCIENTIFIC, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HCY Rapid Quantitative Test
UID: IMP/IVD/2022/000035_8cfbbd99a8097a32f8c4e33198fedaaf_eddebe058b0936f47f9007e5865e997f

License Holder

DIYA SCIENTIFIC

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Biotime HCY Rapid Quantitative Test is intended to quantify the concentration of HCY in human plasma on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of homocysteinemia. -Fluorescence immunoassay -Homocysteinemia For in vitro diagnostic use only. For professional use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing